Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomimetic polyphenol-coated nanoparticles by Co-assembly of mTOR inhibitor and photosensitizer for synergistic chemo-photothermal therapy
Jingqing Le, Fang Yang, Meng-Die Yin, et al.
Colloids and Surfaces B Biointerfaces (2021) Vol. 209, pp. 112177-112177
Closed Access | Times Cited: 11

Showing 11 citing articles:

Engineering polyphenol-based polymeric nanoparticles for drug delivery and bioimaging
Xinyu Wang, Yeli Fan, Junjie Yan, et al.
Chemical Engineering Journal (2022) Vol. 439, pp. 135661-135661
Closed Access | Times Cited: 73
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 11
Multifunctional Theranostic 2D Vanadium Carbidel for Enhanced Cancer Immunotherapy
Keke Feng, Chenglei Li, Rui Xiong, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 5
Advances in Pure Drug Self-Assembled Nanosystems: A Novel Strategy for Combined Cancer Therapy
Runyan Niu, Xuexue Liu, Xian Yang, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 68-68
Open Access
Precise RNA Editing: Cascade Self‐Uncloaking Dual‐Prodrug Nanoassemblies Based on CRISPR/Cas13a for Pleiotropic Immunotherapy of PD‐L1‐Resistant Colorectal Cancer
Bingchen Zhang, Yuehua Wang, Shengtao Wang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 46
Closed Access | Times Cited: 9
Advance Progress in Assembly Mechanisms of Carrier-Free Nanodrugs for Cancer Treatment
Xiaoyu Zhang, S. Hu, Lifei Huang, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7065-7065
Open Access | Times Cited: 8
Recent advances on the application of nanobiomimetic structures as drug delivery systems
Seyyed Behnam Abdollahi Boraei, Sadaf Javadpour, Fatemeh Kamali Nejad, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106009-106009
Closed Access | Times Cited: 2
Polyphenol‐Based Nanosystems for Next‐Generation Cancer Therapy: Multifunctionality, Design, and Challenges
Chenqian Feng, Bo Chen, Rangrang Fan, et al.
Macromolecular Bioscience (2023) Vol. 23, Iss. 11
Closed Access | Times Cited: 7
Dual-drug controllable co-assembly nanosystem for targeted and synergistic treatment of hepatocellular carcinoma
Jingqing Le, Xun-Huan Song, Ling-Wu Tong, et al.
Journal of Colloid and Interface Science (2023) Vol. 656, pp. 177-188
Closed Access | Times Cited: 7
Carrier-free nanomedicines: Mechanisms of formation and biomedical applications
Xinrui Dong, Hu Liu, Haibao Liu, et al.
Giant (2024) Vol. 18, pp. 100256-100256
Open Access
Functional Nanoparticles Encapsulated in Resveratrol-Formaldehyde Resin for Cancer Therapy
Shulin Du, Wenjing Wang, Shuwei Liu, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 24, pp. 22884-22896
Closed Access | Times Cited: 1
Page 1

Scroll to top